New Stock News | Yanmei Biotechnology Submits Application to Hong Kong Stock Exchange with 13 Main Candidates for Regenerative Medicine Material Injection Products.

According to the Zhitong Finance APP, it was disclosed by the Hong Kong Stock Exchange on May 12 that Oriental Yumei (Chengdu) Biotechnology Co., Ltd. (hereinafter referred to as Yumei Biotech) has submitted an application to list on the main board of the Hong Kong Stock Exchange, with CCB International as its sole sponsor.